Adagio Therapeutics’ $356 Million Initial Public Offering

Davis Polk advised the representatives of the several underwriters in the offering.Adagio Therapeutics, Inc. executed the initial public offering of 20,930,000 shares of its common stock at $17.00…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now